Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 December, 2014 07:30 IST
`Buy` Alembic Pharma; target Rs 77: Angel Broking
Source: IRIS Exclusive | 09 Feb, 2012, 01.14PM
Comments  |  Post Comment

Angel Broking has recommended `Buy` on Alembic Pharmaceuticals with a price target of Rs 77 in its report dated Feb. 09, 2012. The broking house gave the following rationale:

For 3QFY2012, Alembic Pharmaceuticals` net sales came in at Rs 3.83 billion, up 15.0% yoy. During the quarter, exports rose by 45.4% yoy to Rs 1.65 billion. While sales were just in-line with our estimate, OPMs came in at 18%, higher than our expectation of 14%. Net profit for the quarter came in at  Rs 4.42 billion.

We maintain our Buy recommendation on the stock with a target price of Rs 77.

Click here to view full report

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer